BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jan A, Gonçalves NP, Vaegter CB, Jensen PH, Ferreira N. The Prion-Like Spreading of Alpha-Synuclein in Parkinson's Disease: Update on Models and Hypotheses. Int J Mol Sci 2021;22:8338. [PMID: 34361100 DOI: 10.3390/ijms22158338] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Dolgacheva LP, Zinchenko VP, Goncharov NV. Molecular and Cellular Interactions in Pathogenesis of Sporadic Parkinson Disease. IJMS 2022;23:13043. [DOI: 10.3390/ijms232113043] [Reference Citation Analysis]
2 Ziaunys M, Smirnovas V. Exploring Epigallocatechin-3-Gallate Autoxidation Products: Specific Incubation Times Required for Emergence of Anti-Amyloid Properties. Antioxidants 2022;11:1887. [DOI: 10.3390/antiox11101887] [Reference Citation Analysis]
3 Mysiris DS, Vavougios GD, Karamichali E, Papoutsopoulou S, Stavrou VT, Papayianni E, Boutlas S, Mavridis T, Foka P, Zarogiannis SG, Gourgoulianis K, Xiromerisiou G. Post-COVID-19 Parkinsonism and Parkinson’s Disease Pathogenesis: The Exosomal Cargo Hypothesis. IJMS 2022;23:9739. [DOI: 10.3390/ijms23179739] [Reference Citation Analysis]
4 Gonzalez De La Cruz E, Vo Q, Moon K, McFarland KN, Weinrich M, Williams T, Giasson BI, Chakrabarty P. MhcII Regulates Transmission of α-Synuclein-Seeded Pathology in Mice. Int J Mol Sci 2022;23:8175. [PMID: 35897751 DOI: 10.3390/ijms23158175] [Reference Citation Analysis]
5 Butler YR, Liu Y, Kumbhar R, Zhao P, Gadhave K, Wang N, Li Y, Mao X, Wang W. α-Synuclein fibril-specific nanobody reduces prion-like α-synuclein spreading in mice. Nat Commun 2022;13:4060. [PMID: 35853942 DOI: 10.1038/s41467-022-31787-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A. GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight. Cells 2022;11:2023. [DOI: 10.3390/cells11132023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Höllerhage M, Klietz M, Höglinger GU. Disease modification in Parkinsonism: obstacles and ways forward. J Neural Transm (Vienna) 2022. [PMID: 35695938 DOI: 10.1007/s00702-022-02520-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chavarría C, Ivagnes R, Souza JM. Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation. Biomolecules 2022;12:655. [DOI: 10.3390/biom12050655] [Reference Citation Analysis]
9 Yu HJ, Thijssen E, Brummelen E, Plas JL, Radanovic I, Moerland M, Hsieh E, Groeneveld GJ, Dodart J. A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide Vaccine. Movement Disorders. [DOI: 10.1002/mds.29016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Boag MK, Roberts A, Uversky VN, Ma L, Richardson DR, Pountney DL. Ferritinophagy and α-Synuclein: Pharmacological Targeting of Autophagy to Restore Iron Regulation in Parkinson's Disease. Int J Mol Sci 2022;23:2378. [PMID: 35216492 DOI: 10.3390/ijms23042378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kwon DH, Hwang JS, Kim SG, Jang YE, Shin TH, Lee G. Cerebrospinal Fluid Metabolome in Parkinson's Disease and Multiple System Atrophy. Int J Mol Sci 2022;23:1879. [PMID: 35163800 DOI: 10.3390/ijms23031879] [Reference Citation Analysis]
12 Van Den Berge N, Ulusoy A. Animal models of brain-first and body-first Parkinson's disease. Neurobiology of Disease 2022;163:105599. [DOI: 10.1016/j.nbd.2021.105599] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
13 Folke J, Ferreira N, Brudek T, Borghammer P, Van Den Berge NVD. Passive Immunization in Alpha-Synuclein Preclinical Animal Models. Biomolecules 2022;12:168. [DOI: 10.3390/biom12020168] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
14 Yuan X, Yang Y, Xia D, Meng L, He M, Liu C, Zhang Z. Silica Nanoparticles Promote α-Synuclein Aggregation and Parkinson’s Disease Pathology. Front Neurosci 2022;15:807988. [DOI: 10.3389/fnins.2021.807988] [Reference Citation Analysis]
15 Srivastava A, Kataria A, Yadav DK, Han I, Choi E. Interplay of alpha-synuclein pathology and gut microbiome in Parkinson’s disease. Human-Gut Microbiome 2022. [DOI: 10.1016/b978-0-323-91313-3.00003-9] [Reference Citation Analysis]
16 De Luca CMG, Consonni A, Cazzaniga FA, Bistaffa E, Bufano G, Quitarrini G, Celauro L, Legname G, Eleopra R, Baggi F, Giaccone G, Moda F. The Alpha-Synuclein RT-QuIC Products Generated by the Olfactory Mucosa of Patients with Parkinson’s Disease and Multiple System Atrophy Induce Inflammatory Responses in SH-SY5Y Cells. Cells 2021;11:87. [DOI: 10.3390/cells11010087] [Reference Citation Analysis]
17 Han S, Seo MH, Lim S, Yeo S. Decrease in ITGA7 Levels Is Associated with an Increase in α-Synuclein Levels in an MPTP-Induced Parkinson's Disease Mouse Model and SH-SY5Y Cells. Int J Mol Sci 2021;22:12616. [PMID: 34884422 DOI: 10.3390/ijms222312616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Padilla-Godínez FJ, Ramos-Acevedo R, Martínez-Becerril HA, Bernal-Conde LD, Garrido-Figueroa JF, Hiriart M, Hernández-López A, Argüero-Sánchez R, Callea F, Guerra-Crespo M. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders. Int J Mol Sci 2021;22:12467. [PMID: 34830348 DOI: 10.3390/ijms222212467] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Ziaunys M, Sakalauskas A, Mikalauskaite K, Smirnovas V. Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration. Int J Mol Sci 2021;22:12382. [PMID: 34830264 DOI: 10.3390/ijms222212382] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
20 Martínez-Menárguez JÁ, Martínez-Alonso E, Cara-Esteban M, Tomás M. Focus on the Small GTPase Rab1: A Key Player in the Pathogenesis of Parkinson's Disease. Int J Mol Sci 2021;22:12087. [PMID: 34769517 DOI: 10.3390/ijms222112087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Li J, Zhang F. Amyloids as Building Blocks for Macroscopic Functional Materials: Designs, Applications and Challenges. Int J Mol Sci 2021;22:10698. [PMID: 34639037 DOI: 10.3390/ijms221910698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jellinger KA, Wenning GK, Stefanova N. Is Multiple System Atrophy a Prion-like Disorder? Int J Mol Sci 2021;22:10093. [PMID: 34576255 DOI: 10.3390/ijms221810093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]